Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease)

According to recommendations of the 6th WHO Advisory Committee on Buruli ulcer, directly observed treatment with the combination of rifampin and streptomycin, administered daily for 8 weeks, was recommended to 310 patients diagnosed with Buruli ulcer in Pobè, Bénin. Among the 224 (72%) eligible pati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chauty, Annick, Ardant, Marie-Françoise, Adeye, Ambroise, Euverte, Hélène, Guédénon, Augustin, Johnson, Christian, Aubry, Jacques, Nuermberger, Eric, Grosset, Jacques
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2007
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2151409/
https://ncbi.nlm.nih.gov/pubmed/17526760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00175-07
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars